This is BrainsWay’s global website. The website includes information on clinical indications that were not cleared by the FDA and are considered investigational by the U.S. medical device regulations. BrainsWay D treatment is FDA cleared for patients with MDD who failed to respond to one or more anti-depressants in the current episode.
VP Field and Clinical Operations
Mr Ginou manages the Field and Clinical Operations at BrainsWay.
Prior to this, he served as the Clinical Trials Manager at BrainsWay, conducting dozens of clinical trials at different phases to explore the efficacy and safety of BrainsWay Deep TMS for diverse clinical indications.
Amit holds a B.Sc. degree in Neuroscience from Bar-Ilan University, and an MA Law degree from Bar-Ilan University.